FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference133 articles.
1. Advances in acute myeloid leukemia differentiation therapy: A critical review;Abdel-Aziz;Biochem. Pharmacol.,2023
2. From resistance to sensitivity: insights and implications of biphasic modulation of autophagy by sunitinib;Abdel-Aziz;Front. Pharmacol.,2017
3. Modulation of imatinib cytotoxicity by selenite in HCT116 colorectal cancer cells;Abdel-Aziz;Basic Clin. Pharmacol. Toxicol.,2015
4. The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries;Abdel-Aziz;Exp. Neurol.,2016
5. Comparing apples with oranges: Studying LSD1 inhibitors in cellular assays;Abdel-Aziz;Pharmacol. Res.,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations;Journal of Medicinal Chemistry;2024-09-11
2. Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment;Chinese Chemical Letters;2024-09
3. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis;Cell Communication and Signaling;2024-08-07
4. Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations;ACS Pharmacology & Translational Science;2024-04-11
5. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells;Frontiers in Immunology;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3